References
- Lan C, Li Y, Liu J. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol. 2009;114(1):42–47.10.1016/j.ygyno.2009.03.034
- Lengyel E, Burdette JE, Kenny HA, et al. Epithelial ovarian cancer experimental models. Oncogene. 2014;33(28):3619–3633.10.1038/onc.2013.321
- Klug TL, Bast RC Jr, Niloff JM, et al. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 1984;44(3):1048–1053.
- Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2000;176:528–535.
- Heizmann CW, Ackermann GE, Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell Biochem. 2007;45:93–138.10.1007/978-1-4020-6191-2
- Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med. 2007;7:711–724.10.2174/156652407783220688
- El-Abd E, El-Tahan R, Fahmy L, et al. Serum metastasin mRNA is an important survival predictor in breast cancer. Br J Biomed Sci. 2008;65(2):90–94.10.1080/09674845.2008.11732804
- Ismail MF, El Boghdady NA, Shabayek MI, et al. Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt. Tumour Biol. 2016;37(4):4621–4631.10.1007/s13277-015-4264-7
- Yan W, Chen J, Chen Z, et al. Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer. Am J Cancer Res. 2016;6(2):260–269.
- Maelandsmo GM, Flørenes VA, Nguyen MT, et al. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites. Tumour Biol. 2009;30(1):15–25.10.1159/000199447
- Kikuchi N, Horiuchi A, Osada R, et al. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression. Cancer Sci. 2006;97(10):1061–1069.10.1111/cas.2006.97.issue-10
- Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96–109.10.1038/nrc3893
- Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 2012;31(1–2):163–172.10.1007/s10555-011-9338-4
- Rustin GJ, van der Burg ME, Griffin CL, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet. 2010;376:1155–1163.10.1016/S0140-6736(10)61268-8